Bone Biologics Corp
Last updated September 27, 2026
Organization details
- Legal name
- Bone Biologics Corp
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BBLG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001419554
Board of directors
-
Bruce Stroever · DirectorSince 2023
-
Don Hankey · Director · Chairman of the BoardSince 2023
-
Erick Lucera · DirectorSince 2023
-
Phillip Terry Meikle II · DirectorSince 2024
-
Robert E. Gagnon · DirectorSince 2024
-
Siddhesh Rajendra Angle · DirectorSince 2023
Board connections
2 of this board's directors also sit on 3 other boards.
- via Erick Lucera
- via Erick Lucera
- via Robert E. Gagnon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 13, 2023 | Walsh Deina H Officer (Chief Financial Officer) | Open-market purchase | +8,000 | $0.64 | $5,120 |
| Sep 11, 2023 | Frelick Jeff Officer (Chief Executive Officer) | Open-market purchase | +9,500 | $0.69 | $6,555 |
| Sep 6, 2023 | Walsh Deina H Officer (Chief Financial Officer) | Open-market purchase | +300 | $0.70 | $210 |
| Sep 6, 2023 | Walsh Deina H Officer (Chief Financial Officer) | Open-market purchase | +6,700 | $0.71 | $4,757 |
| Aug 31, 2023 | Frelick Jeff Officer (Chief Executive Officer) | Open-market purchase | +7,600 | $0.66 | $5,016 |
| Mar 13, 2023 | Don Hankey Director, Officer (Chairman of the Board), 10% owner | Other | −500,137 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.